Literature DB >> 23370427

Deparaffinization and lysis by hydrothermal pressure (pressure cooking) coupled with chaotropic salt column purification: a rapid and efficient method of DNA extraction from formalin-fixed paraffin-embedded tissue.

Haohao Zhong1, Yan Liu, Monica Talmor, Bingquan Wu, Pei Hui.   

Abstract

We report a hydrothermal pressure method (pressure cooking) for simultaneous deparaffinization and lysis of formalin-fixed paraffin-embedded tissue followed by conventional chaotropic salt column purification to obtain high-quality DNA. Using this method, the release of DNA occurred within the first minute of treatment, reaching the maximum at 5 minutes. An optimal treatment window was between 5 and 30 minutes. The extracted DNA was of high quality as determined by the 260/280 absorbance ratios, and the quantity of DNA extracted was linear with the input tissue amount. In paired sample experiments (N=19), the quantity of DNA extracted by hydrothermal pressure treatment was comparable to that obtained through the conventional xylene deparaffinization and protease K digestion method. The integrity of the recovered DNA was also comparable, evidenced by polymerase chain reaction amplifications of variable-sized amplicons in tissue samples archived from 0.2 to 22 years (N=14). The high quality of DNA was further confirmed by polymerase chain reaction amplification and Sanger sequencing analysis of representative exons of the EGFR gene in human non-small cell lung cancer tissue samples. In summary, this novel method offers DNA release from formalin-fixed paraffin-embedded tissue with unprecedented simplicity, speed, biohazard safety, and cost-efficiency. Combined with chaotropic salt column purification, high-quality DNA can be prepared for downstream applications in <30 minutes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370427     DOI: 10.1097/PDM.0b013e318263f092

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  8 in total

1.  KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.

Authors:  Ju-Xiang Ye; Yan Liu; Yun Qin; Hao-Hao Zhong; Wei-Ning Yi; Xue-Ying Shi
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis.

Authors:  Olivia L Snir; Maura DeJoseph; Serena Wong; Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

3.  STR DNA genotyping of hydatidiform moles in South China.

Authors:  Xing-Zheng Zheng; Pei Hui; Bin Chang; Zhi-Bin Gao; Yan Li; Bing-Quan Wu; Bo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

4.  Identification of a hydatidiform mole in twin pregnancy following assisted reproduction.

Authors:  Yan Liu; Xingzheng Zheng; Yuxiang Wang; Yan Li; Congrong Liu
Journal:  J Assist Reprod Genet       Date:  2019-12-12       Impact factor: 3.412

5.  Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.

Authors:  Xing-Zheng Zheng; Xu-Ying Qin; Su-Wen Chen; Peng Wang; Yang Zhan; Ping-Ping Zhong; Natalia Buza; Yu-Lan Jin; Bing-Quan Wu; Pei Hui
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

6.  Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.

Authors:  Yan Liu; Bing-Quan Wu; Hao-Hao Zhong; Pei Hui; Wei-Gang Fang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

7.  Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.

Authors:  Yuxin Liu; Morgan Blakely; Keith Sigel; Tin Htwe Thin; Pei Hui; Michael Donovan; Michael M Gaisa
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

8.  KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome.

Authors:  Tao Zuo; Serena Wong; Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.